ctrl K

Avidity Biosciences Inc. (RNA)

NASDAQ: RNA · Real-Time Price · USD

32.74

0.09 (0.28%)

At close: May 01, 2025, 3:59 PM

32.69

-0.15%

After-hours: May 01, 2025, 04:05 PM EDT

Avidity Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	10.9M	9.56M	9.22M	9.33M	6.79M	2.32M	379K
Cost of Revenue	n/a	2.1M	1.39M	639K	37.6M	14.54M	8.44M
Gross Profit	10.9M	7.46M	7.84M	8.69M	-30.82M	-12.22M	-8.06M
Operating Income	-378.94M	-235.6M	-178.91M	-118.05M	-44.28M	-17.33M	-10.5M
Interest Income	56.88M	23.97M	4.97M	104K	206K	7.39M	n/a
Pretax Income	-322.3M	-212.22M	-174M	-118.01M	-44.35M	-24.73M	-11.22M
Net Income	-322.3M	-212.22M	-169.08M	-117.37M	-43.98M	-32.12M	-11.93M
Selling & General & Admin	86.24M	54.19M	37.73M	26.2M	13.46M	5.11M	2.44M
Research & Development	303.59M	190.97M	150.4M	101.18M	37.6M	14.54M	8.44M
Other Expenses	n/a	n/a	4.92M	42K	-78K	n/a	n/a
Operating Expenses	389.83M	245.16M	188.14M	127.38M	51.06M	19.65M	10.88M
Interest Expense	n/a	n/a	n/a	n/a	209K	7.39M	718K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	389.83M	245.16M	188.14M	127.38M	51.06M	19.65M	10.88M
Income Tax Expense	n/a	n/a	-4.92M	-639K	-373K	7.39M	718K
Shares Outstanding (Basic)	111.58M	73.01M	52.16M	41.43M	21.66M	37.51M	20.68M
Shares Outstanding (Diluted)	111.58M	73.01M	52.16M	41.43M	21.66M	37.51M	20.68M
EPS (Basic)	-2.89	-2.91	-3.24	-2.83	-2.03	-0.86	-0.58
EPS (Diluted)	-2.89	-2.91	-3.24	-2.83	-2.03	-0.86	-0.58
EBITDA	-378.94M	-233.5M	-177.53M	-117.41M	-43.77M	-16.75M	-10.12M
EBIT	-378.94M	-235.6M	-178.91M	-118.05M	-44.15M	-17.35M	-10.5M
Depreciation & Amortization	n/a	2.1M	1.39M	639K	373K	597K	383K